Sun Biomedical (ASX:SBN) Short-Term Debt : A$1.43 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sun Biomedical Short-Term Debt?

Sun Biomedical's Short-Term Debt for the quarter that ended in Dec. 2023 was A$1.43 Mil.

Sun Biomedical's quarterly Short-Term Debt increased from Dec. 2022 (A$0.05 Mil) to Jun. 2023 (A$5.94 Mil) but then declined from Jun. 2023 (A$5.94 Mil) to Dec. 2023 (A$1.43 Mil).

Sun Biomedical's annual Short-Term Debt declined from Jun. 2021 (A$5.05 Mil) to Jun. 2022 (A$0.00 Mil) but then increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$5.94 Mil).

Sun Biomedical Short-Term Debt Historical Data

The historical data trend for Sun Biomedical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Biomedical Short-Term Debt Chart

Sun Biomedical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

Get a 7-Day Free Trial

1.06

5.05

5.94

Sun Biomedical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															0.02	-	0.05	5.94	1.43

Sun Biomedical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sun Biomedical Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Sun Biomedical's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Biomedical (ASX:SBN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

DXB:Australia

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines